Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
China Journal of Orthopaedics and Traumatology ; (12): 617-620, 2014.
Artigo em Chinês | WPRIM | ID: wpr-249304

RESUMO

Osteoarthritis (OA) is a complex chronic progressive disease attacked by biological and mechanical factors and a result from the anabolic and catabolic imbalance in chondrocyte, subchondral bone and extracellular matrix(ECM). Etiology and pathological of OA are not yet entirely clear. The degradation and destruction of collagen II caused by matrix metalloproteinase -13 (MMP-13) is considered the core factor in the occurrence and development of OA. The research of MMP-13 inhibitor provide ideas and methods for the treatment of OA. In this article,the role and determination of MMP-13 in OA and the development prospect of MMP-13 inhibitor in the treatment of OA research progress were reviewed.


Assuntos
Animais , Humanos , Colágeno , Metabolismo , Metaloproteinase 13 da Matriz , Fisiologia , Inibidores de Metaloproteinases de Matriz , Usos Terapêuticos , Osteoartrite , Tratamento Farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA